Medistim ASA Net Asset Quality Index
Medistim ASA net asset quality index. Medistim ASA (MEDI) has a Net Asset Quality Index of 71.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr535.04 Million minus total liabilities of Nkr151.23 Million yields net assets of Nkr383.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Medistim ASA to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Medistim ASA (2004–2024)
Net asset quality index of Medistim ASA from 2004 to 2024. This chart shows how Medistim ASA's Net Asset Quality Index has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the index stands at 71.7%, representing net assets of Nkr383.81 Million against total assets of Nkr535.04 Million NOK. See what is Medistim ASA's book value for net asset value and shareholders' equity analysis.
Medistim ASA Net Asset Quality Index by Year (2004–2024)
Medistim ASA net asset quality index by year from 2004 to 2024. The table below presents the year-by-year Net Asset Quality Index for Medistim ASA from 2004 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Medistim ASA (MEDI) market capitalisation.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.9% | Nkr436.61 Million | Nkr574.97 Million | Nkr138.36 Million | ▼ -2.8 pp |
| 2023 | 78.7% | Nkr397.94 Million | Nkr505.72 Million | Nkr107.78 Million | ▲ +2.5 pp |
| 2022 | 76.2% | Nkr367.69 Million | Nkr482.66 Million | Nkr114.97 Million | ▲ +0.3 pp |
| 2021 | 75.9% | Nkr306.05 Million | Nkr403.24 Million | Nkr97.19 Million | ▲ +1.6 pp |
| 2020 | 74.3% | Nkr256.85 Million | Nkr345.82 Million | Nkr88.97 Million | ▲ +3.8 pp |
| 2019 | 70.5% | Nkr236.86 Million | Nkr336.11 Million | Nkr99.25 Million | ▼ -6.2 pp |
| 2018 | 76.7% | Nkr206.71 Million | Nkr269.59 Million | Nkr62.88 Million | ▲ +3.8 pp |
| 2017 | 72.9% | Nkr182.98 Million | Nkr251.06 Million | Nkr68.08 Million | ▼ -3.9 pp |
| 2016 | 76.8% | Nkr166.70 Million | Nkr217.05 Million | Nkr50.34 Million | ▲ +5.3 pp |
| 2015 | 71.5% | Nkr156.16 Million | Nkr218.44 Million | Nkr62.27 Million | ▲ +3.1 pp |
| 2014 | 68.4% | Nkr139.10 Million | Nkr203.49 Million | Nkr64.39 Million | ▼ -3.9 pp |
| 2013 | 72.2% | Nkr121.64 Million | Nkr168.39 Million | Nkr46.76 Million | ▼ -3.6 pp |
| 2012 | 75.8% | Nkr115.17 Million | Nkr151.87 Million | Nkr36.70 Million | ▲ +4.4 pp |
| 2011 | 71.4% | Nkr106.89 Million | Nkr149.63 Million | Nkr42.74 Million | ▼ -2.5 pp |
| 2010 | 73.9% | Nkr107.83 Million | Nkr145.94 Million | Nkr38.11 Million | ▲ +0.9 pp |
| 2009 | 73.0% | Nkr106.29 Million | Nkr145.63 Million | Nkr39.33 Million | ▲ +7.3 pp |
| 2008 | 65.7% | Nkr95.46 Million | Nkr145.38 Million | Nkr49.92 Million | ▼ -7.2 pp |
| 2007 | 72.9% | Nkr93.83 Million | Nkr128.79 Million | Nkr34.96 Million | ▲ +10.7 pp |
| 2006 | 62.2% | Nkr74.06 Million | Nkr119.15 Million | Nkr45.09 Million | ▼ -17.2 pp |
| 2005 | 79.3% | Nkr67.41 Million | Nkr85.00 Million | Nkr17.58 Million | ▼ -3.9 pp |
| 2004 | 83.2% | Nkr61.71 Million | Nkr74.19 Million | Nkr12.47 Million | — |